CalciTech Files Three Months Statements.Business Editors HAMILTON, Bermuda--(BUSINESS WIRE)--Aug. 13, 2001 CalciTech Ltd (OTC OTC See: Over-the-counter. OTC See over-the-counter market (OTC). BB: CLKTF, CDNX CDNX See Canadian Venture Exchange (CDNX). : CLK CLK Clock CLK Clerk CLK CDC2-Like Kinase CLK Corel RAVE (file extension) CLK Chep Lap Kok (Hong Kong airport) CLK Ceska Lekarska Komora (Chech) ) announces that it filed in July 2001, with the SEC, BCSC BCSC British Columbia Securities Commission BCSC British Columbia Supreme Court BCSC British Council of Shopping Centres BCSC Breast Cancer Society of Canada BCSC Breast Cancer Surveillance Consortium BCSC British Columbia Safety Council and CDNX its Unaudited Consolidated Report and Financial Statements for the three months ended May 31, 2001. The accounts show a net loss of US$ 554,000, much in line with the same period in 2000 of US$548,000. General and Administrative costs administrative costs, n.pl the overhead expenses incurred in the operation of a dental benefits program, excluding costs of dental services provided. are slightly up at US$ 210,000 from US$ 182,000 and Research and development costs have been reduced to US$ 271,000 as compared with US$ 321,000 in the same period, while overhead is generally the same as the previous year. During the period the company has continued to work on it's various projects in Norway, and Germany, while developing further project opportunities. During this period, the company established a technical centre near its administrative offices in France. The centre is equipped with all the necessary apparatus and tools to allow the initial feasibility assessment of raw materials, such as carbide lime or other impure im·pure adj. im·pur·er, im·pur·est 1. Not pure or clean; contaminated. 2. Not purified by religious rite; unclean. 3. Immoral or sinful: impure thoughts. materials, for its process to convert these into a variety of high quality PCC's. CalciTech also announces the termination of the services of North American investor relations firm Dot Com Consulting Corporation. Investor relations will be carried out by CalciTech from its offices in France until new arrangements are made in the autumn. CalciTech continues to focus on the development of its environmentally friendly technology for the production of PCC PCC prothrombin complex concentrate. , which has potential applications in a wide range of markets. This press release contains forward-looking statements which are subject to a number of contingencies and uncertainties, including but not limited to, market acceptance for CalciTech products, manufacturing of CalciTech products in a commercial setting, obtaining adequate financing and construction management for products and obtaining appropriate permits. Such forward-looking statements are not guarantees of future performance, and are based on numerous assumptions about future conditions that could change. No Stock Exchange has reviewed or accepted responsibility for the adequacy or accuracy of this press release. For More Information, visit www.calcitech.com. |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion